Published in Oncogene on July 11, 2011
Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer (2013) 4.46
Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms. Cancer Cell (2016) 1.46
PTEN-deficient tumors depend on AKT2 for maintenance and survival. Cancer Discov (2014) 1.03
In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes. Cancer Discov (2015) 1.02
Pten loss in the bone marrow leads to G-CSF-mediated HSC mobilization. J Exp Med (2013) 1.02
Opposing functions of Akt isoforms in lung tumor initiation and progression. PLoS One (2014) 0.99
AKT/PKB Signaling: Navigating the Network. Cell (2017) 0.87
Preclinical Remodeling of Human Prostate Cancer through the PTEN/AKT Pathway. Adv Urol (2012) 0.86
A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability. Oncotarget (2016) 0.84
Influence of AKT on progesterone action in endometrial diseases. Biol Reprod (2014) 0.80
Systemic Akt1 Deletion after Tumor Onset in p53(-/-) Mice Increases Lifespan and Regresses Thymic Lymphoma Emulating p53 Restoration. Cell Rep (2015) 0.80
Hepatocyte nuclear factor 1α suppresses steatosis-associated liver cancer by inhibiting PPARγ transcription. J Clin Invest (2017) 0.75
Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases. Biosci Rep (2017) 0.75
Akt as a target for cancer therapy: more is not always better (lessons from studies in mice). Br J Cancer (2017) 0.75
Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst (2000) 16.92
Pten is essential for embryonic development and tumour suppression. Nat Genet (1998) 13.41
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A (1999) 11.38
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science (2001) 11.22
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A (1999) 7.88
Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem (2001) 7.10
High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol (1998) 6.38
The two TORCs and Akt. Dev Cell (2007) 6.17
Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev (2001) 6.15
Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet (2001) 5.92
Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol (2005) 5.00
Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest (2003) 4.79
Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res (1997) 4.73
Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res (1997) 4.32
Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell (2006) 3.83
High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. Cancer Res (2000) 3.24
Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res (2007) 3.13
The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice. Genes Dev (2006) 2.76
Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha. Biochem J (1998) 2.73
Akt1 governs breast cancer progression in vivo. Proc Natl Acad Sci U S A (2007) 2.67
Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res (2001) 2.51
Prostatic intraepithelial neoplasia in genetically engineered mice. Am J Pathol (2002) 2.48
MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells. Sci Signal (2009) 2.38
Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Res (2010) 2.13
The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration. Mol Cell (2010) 1.53
The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation: a 2009 update. Curr Top Med Chem (2010) 1.29
Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice. Mol Cell Biol (2009) 1.19
Insulin, insulin resistance, obesity, and cancer. Curr Diab Rep (2010) 1.07
PTEN and cancer. Methods Mol Biol (2003) 1.02
Allosteric inhibitors of Akt1 and Akt2: discovery of [1,2,4]triazolo[3,4-f][1,6]naphthyridines with potent and balanced activity. Bioorg Med Chem Lett (2008) 0.86
4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev (1998) 6.89
Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev (2001) 6.15
The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev (1997) 5.58
Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev (2001) 5.12
The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res (1999) 4.66
Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev (1994) 3.70
Attenuation in the control of SV40 gene expression. Cell (1982) 3.32
Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene (2006) 3.17
Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci U S A (2001) 3.02
Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol Cell Biol (1999) 2.93
High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc Natl Acad Sci U S A (2002) 2.85
Neoplastic transformation by the human gene N-myc. Mol Cell Biol (1987) 2.17
Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Mol Endocrinol (1998) 2.06
Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. Mol Cell Biol (1993) 1.79
Sequence-specific transcriptional activation by Myc and repression by Max. Mol Cell Biol (1993) 1.77
c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ (1993) 1.60
Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. Cancer Res (1994) 1.52
Attenuation of late simian virus 40 mRNA synthesis is enhanced by the agnoprotein and is temporally regulated in isolated nuclear systems. Mol Cell Biol (1985) 1.43
Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol Cell Biol (1998) 1.41
The role of RNA molecules in transduction of the proto-oncogene c-fps. Cell (1986) 1.39
Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, Max, for positive regulation of cardiac alpha-myosin heavy-chain gene expression. Mol Cell Biol (1997) 1.37
Attenuation in SV40 as a mechanism of transcription-termination by RNA polymerase B. Nucleic Acids Res (1984) 1.35
Repeated CT elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters. Mol Cell Biol (1993) 1.29
Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. J Neurosci (1999) 1.24
Attenuation may regulate gene expression in animal viruses and cells. CRC Crit Rev Biochem (1985) 1.21
Site of premature termination of late transcription of simian virus 40 DNA: enhancement by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. Proc Natl Acad Sci U S A (1982) 1.20
Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis. Mol Cell Biol (2000) 1.18
Activation of NF-kappa B by bradykinin through a Galpha(q)- and Gbeta gamma-dependent pathway that involves phosphoinositide 3-kinase and Akt. J Biol Chem (2000) 1.17
p21 Disrupts the interaction between cdk2 and the E2F-p130 complex. Mol Cell Biol (1996) 1.16
Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea. Clin Microbiol Infect (2008) 1.16
Transcription termination in animal viruses and cells. Gene (1988) 1.06
A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function. Oncogene (2001) 1.05
In vitro premature termination in SV40 late transcription. EMBO J (1983) 1.02
A kinetic analysis of the nucleotide-induced allosteric transitions of GroEL. J Mol Biol (1999) 1.02
Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation. Cancer Res (1996) 0.99
Expression, regulation, and chromosomal localization of the Max gene. Proc Natl Acad Sci U S A (1992) 0.98
Role of the intramolecular phase in high-harmonic generation. Phys Rev Lett (2002) 0.96
Control of late simian virus 40 transcription by the attenuation mechanism and transcriptionally active ternary complexes are associated with the nuclear matrix. J Mol Biol (1984) 0.96
Secular trends of healthcare-associated infections at a teaching hospital in Taiwan, 1981-2007. J Hosp Infect (2010) 0.96
Attenuation and modulation of mRNA secondary structure in a feedback control system regulating SV40 gene expression. Mol Biol Rep (1983) 0.94
Novel bioequivalence approach for narrow therapeutic index drugs. Clin Pharmacol Ther (2014) 0.93
Unusual acute promyelocytic leukemia following de novo renal transplant: case report and literature review. Clin Nephrol (2011) 0.89
Retracted Blockage of the early events of mitogenic signaling by interferon-gamma in macrophages in response to colony-stimulating factor-1. Blood (1995) 0.88
Antibiotic resistance and molecular typing of Photobacterium damselae subsp. damselae, isolated from seafood. J Appl Microbiol (2013) 0.86
Apoptosis induced by differentiation or serum deprivation in an immortalized central nervous system neuronal cell line. J Neurochem (1996) 0.86
Identification of a single nucleotide polymorphism at the 5' promoter region of human reelin gene and association study with schizophrenia. Mol Psychiatry (2002) 0.84
Control of vancomycin-resistant enterococci in a hospital: a five-year experience in a Taiwanese teaching hospital. J Hosp Infect (2004) 0.84
Structural analysis of the mouse prosaposin (SGP-1) gene reveals the presence of an exon that is alternatively spliced in transcribed mRNAs. Mol Reprod Dev (1997) 0.83
The coding-synonymous polymorphism rs1045280 (Ser280Ser) in beta-arrestin 2 (ARRB2) gene is associated with tardive dyskinesia in Chinese patients with schizophrenia. Eur J Neurol (2008) 0.82
SV40 deletion mutant (d1861) with agnoprotein shortened by four amino acids. Virology (1984) 0.82
Cucurbitacin-B inhibits neuroblastoma cell proliferation through up-regulation of PTEN. Eur Rev Med Pharmacol Sci (2014) 0.81
Distribution of mouse sulfated glycoprotein-1 (prosaposin) in the testis and other tissues. J Androl (1998) 0.81
Common dental features and craniofacial development of three siblings with Ter Haar syndrome. Eur Arch Paediatr Dent (2013) 0.81
Extrapulmonary infections caused by a dominant strain of Mycobacterium massiliense (Mycobacterium abscessus subspecies bolletii). Clin Microbiol Infect (2013) 0.80
Intrinsic fluorescence studies of the chaperonin GroEL containing single Tyr --> Trp replacements reveal ligand-induced conformational changes. J Biol Chem (1996) 0.80
Palate lengthening by buccinator myomucosal flaps for velopharyngeal insufficiency. Cleft Palate Craniofac J (2012) 0.80
Prolonged vitamin D intoxication: presentation, pathogenesis and progress. Intern Med J (2013) 0.79
Requirement of E. coli DNA synthesis functions for the lytic replication of bacteriophage P1. Virology (1983) 0.79
Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. Mol Neurobiol (2014) 0.78
A morphological study of the left atrial appendage in chinese patients with atrial fibrillation. J Int Med Res (2012) 0.77
Myc drives apoptosis in PC12 cells in the absence of Max. Oncogene (2001) 0.76
Histological changes induced by CO2 laser microprobe specially designed for root canal sterilization: in vivo study. J Clin Laser Med Surg (1998) 0.76
Steroid confusion: another cautionary tale. N Z Med J (1999) 0.75
Trans-cranial placement of an amplatzer device to control intractable cardiac failure in an infant with a vein of galen anomaly. A case report. Interv Neuroradiol (2010) 0.75
Correlation of oestrogen receptor gene polymorphism with gouty arthritis. Ann Rheum Dis (2006) 0.75
Nephropathy in diabetes. N Z Med J (1997) 0.75
Efficient and accurate in vitro processing of simian virus 40-associated small RNA. J Virol (1986) 0.75
Studies on the ignition properties of unipolar and bipolar diathermy probes. Gastrointest Endosc (1989) 0.75
Three years of clinical evaluation of endodontically treated teeth by 15 F CO2 laser microprobe: in vivo study. J Clin Laser Med Surg (1999) 0.75
Control of laser heating in clusters through variation in temporal pulse shape. Opt Express (2003) 0.75
Proceedings: Pseudohypoparathyroidism and pseudo-pseudohypoparathyroidism. Br J Dermatol (1974) 0.75
Characteristics of a specific radioimmunoassay for measurement of ferritin on the surface of peripheral mononuclear white blood cells in cancer patients. J Immunoassay (1984) 0.75
Analysis of chlorthalidone in biological fluids by high-performance liquid chromatography using a rapid column cleanup procedure. Ther Drug Monit (1984) 0.75
Students: looking out for your own. Nurs Stand (1990) 0.75
Management of patients with sickle cell pain in the community. J R Coll Physicians Lond (2000) 0.75
Retraction. Blockage of the early events of mitogenic signaling by interferon-gamma in macrophages in response to colony-stimulating factor-1. Blood (1996) 0.75
Removal of frontal sinus keratoma solely via endoscopic sinus surgery. J Laryngol Otol (2010) 0.75
Adhesive pre-coated brackets, a comparative clinical study. Br J Orthod (1996) 0.75